ProPhase Labs (NASDAQ: PRPH) reported Q1 EPS of $0.03, $0.12 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $16.3 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.